Pharmaceutical

Diabetics more likely to develop cancer and die from the disease

diabetes illus250x03 Diabetics more likely to develop cancer and die from the diseasePeople with type 2 diabetes are more likely to develop cancer and to die from it than non-diabetics, a new study suggests.

Researchers presented their analysis of 20 scientific studies consisting of nearly 2 million people between 2007 and 2012 at the 2013 European Cancer Congress. They found that diabetics had a 23 percent higher risk of developing breast cancer and a 38 percent greater risk of dying from it. They also found diabetics to have a 26 percent higher risk of colon cancer and a 30 percent greater chance of dying from it compared to non-diabetics.

“The evidence is getting quite strong that there is an association between diabetes and cancer,” said lead researcher Kristin De Bruijn. “Worldwide, the numbers of obese and subsequent diabetic patients are still increasing and it is a cause for concern that these individuals are at a higher risk of developing cancer and dying from it.”

Obesity and sedentary lifestyles contribute to the development of type 2 diabetes, a chronic condition in which the body does not produce enough insulin. If not controlled, type 2 diabetes increases the risk of heart disease, kidney disease, dementia and blindness. Most people with diabetes require medication to keep their blood sugar levels under control.

However, many of these drugs have cancer risks. For example, in 2011 the Food and Drug Administration (FDA) warned that the type 2 diabetes medication Actos had been linked to bladder cancer, especially when used long-term. More recently, studies have shown that the drugs Byetta and Januvia can increase the risk for pancreatic cancer.

“It is extremely important that prevention campaigns on obesity and diabetes are intensified and that they also focus on children to prevent them from becoming obese and developing cancer later in life,” De Bruijn added.

Source: Dominican Today